A bone substitute with high affinity for vitamin D-binding protein-relationship with niche of osteoclasts

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 1, 2014, Pages 170-180

  Ikeda, Tohru ^a   Kasai, Michiyuki ^b,d   Tatsukawa, Eri ^a   Kamitakahara, Masanobu ^c   Shibata, Yasuaki ^a   Yokoi, Taishi ^c   Nemoto, Takayuki K ^a   Ioku, Koji ^c,e  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e KEIO UNIVERSITY   (Japan)

Author keywords

Hydroxyapatite; Macrophage activating factor; Osteoclast; Serum proteins; Vitamin D binding protein

Indexed keywords

ANIMALIA; RATTUS;

HYDROXYAPATITE; IMMOBILIZED PROTEIN; IMMUNOGLOBULIN; MACROPHAGE ACTIVATING FACTOR; SERUM ALBUMIN; VITAMIN D BINDING PROTEIN;

ADSORPTION; ANIMAL; ARTICLE; BONE PROSTHESIS; BONE REGENERATION; CELL DIFFERENTIATION; CERAMICS; CHEMISTRY; CHEMOTAXIS; FEMALE; IMPLANT; MACROPHAGE; METABOLISM; OSTEOCLAST; PHYSIOLOGY; PROTEIN BINDING; RAT; SERUM PROTEINS; WISTAR RAT; X RAY DIFFRACTION;

HYDROXYAPATITE; MACROPHAGE ACTIVATING FACTOR; OSTEOCLAST; SERUM PROTEINS; VITAMIN D-BINDING PROTEIN;

ADSORPTION; ANIMALS; BONE REGENERATION; BONE SUBSTITUTES; CELL DIFFERENTIATION; CERAMICS; CHEMOTAXIS; DURAPATITE; FEMALE; GAMMA-GLOBULINS; IMMOBILIZED PROTEINS; IMPLANTS, EXPERIMENTAL; MACROPHAGES; OSTEOCLASTS; PROTEIN BINDING; RATS; RATS, WISTAR; SERUM ALBUMIN; VITAMIN D-BINDING PROTEIN; X-RAY DIFFRACTION;

EID: 84891373707     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12180     Document Type: Article

References (45)

1. Mackenzie-Feder J, Sirrs S, Anderson D, et al. Primary hyperparathyroidism: an overview. Int J Endocrinol. 2011; 2011: 251410.
2. Rodan GA. Bisphosphonates and primary hyperparathyroidism. J Bone Miner Res. 2002; 17: N150-3.
3. Khosla S, Riggs BL. Pathophysiology of age-related bone loss and osteoporosis. Endocrinol Metab Clin North Am. 2005; 34: 1015-30, xi.
4. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003; 423: 337-42.
5. Dacquin R, Domenget C, Kumanogoh A, et al. Control of bone resorption by semaphorin 4D is dependent on ovarian function. PLoS ONE. 2011; 6: e26627.
6. Hayashi M, Nakashima T, Taniguchi M, et al. Osteoprotection by semaphorin 3A. Nature. 2012; 485: 69-74.
7. Negishi-Koga T, Shinohara M, Komatsu N, et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat Med. 2011; 17: 1473-80.
8. Walker EC, McGregor NE, Poulton IJ, et al. Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling. J Bone Miner Res. 2008; 23: 2025-32.
9. Takeshita S, Fumoto T, Matsuoka K, et al. Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation. J Clin Invest. 2013; 123: 3914-24.
10. Ioku K, Yamauchi S, Fujimori H, et al. Hydrothermal preparation of fibrous apatite and apatite sheet. Solid State Iionics. 2002; 151: 147-50.
11. Okuda T, Ioku K, Yonezawa I, et al. The slow resorption with replacement by bone of a hydrothermally synthesized pure calcium-deficient hydroxyapatite. Biomaterials. 2008; 29: 2719-28.
12. Gonda Y, Ioku K, Shibata Y, et al. Stimulatory effect of hydrothermally synthesized biodegradable hydroxyapatite granules on osteogenesis and direct association with osteoclasts. Biomaterials. 2009; 30: 4390-400.
13. Maeno S, Niki Y, Matsumoto H, et al. The effect of calcium ion concentration on osteoblast viability, proliferation and differentiation in monolayer and 3D culture. Biomaterials. 2005; 26: 4847-55.
14. Ahlstrom M, Pekkinen M, Riehle U, et al. Extracellular calcium regulates parathyroid hormone-related peptide expression in osteoblasts and osteoblast progenitor cells. Bone. 2008; 42: 483-90.
15. Yang L, Perez-Amodio S, Barrere-de Groot FY, et al. The effects of inorganic additives to calcium phosphate on in vitro behavior of osteoblasts and osteoclasts. Biomaterials. 2010; 31: 2976-89.
16. 2+ level in osteoblasts (SaOS-2 cells) in vitro. Acta Biomater. 2011; 7: 2661-71.
17. Ikeda T, Gonda Y, Tatsukawa E, et al. Stimulation of osteogenesis in bone defects implanted with biodegradable hydroxyapatite composed of rod-shaped particles under mechanical unloading. Acta Histochem Cytochem. 2012; 45: 283-92.
18. Mendonca DB, Miguez PA, Mendonca G, et al. Titanium surface topography affects collagen biosynthesis of adherent cells. Bone. 2011; 49: 463-72.
19. Valencia S, Gretzer C, Cooper LF. Surface nanofeature effects on titanium-adherent human mesenchymal stem cells. Int J Oral Maxillofac Implants. 2009; 24: 38-46.
20. Takahashi T, Kamitakahara M, Kawachi G, et al. Preparation of spherical porous granules composed of rod-shaped hydroxyapatite and evaluation of their protein adsorption properties. Key Eng Mater. 2008; 361-363: 83-6.
21. Ioku K, Kawachi G, Sasaki S, et al. Hydrothermal preparation of tailored hydroxyapatite. J Meter Sci. 2006; 41: 1341-4.
22. Tiselius A, Hjertén S, Levin Ö. Protein chromatography on calcium phosphate columns. Arch Biochem Biophys. 1956; 65: 132-55.
23. Gorbunoff MJ. The interaction of proteins with hydroxyapatite. I. Role of protein charge and structure. Anal Biochem. 1984; 136: 425-32.
24. Gorbunoff MJ. The interaction of proteins with hydroxyapatite. II. Role of acidic and basic groups. Anal Biochem. 1984; 136: 433-9.
25. Gregory KJ, Zhao B, Bielenberg DR, et al. Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells. PLoS ONE. 2010; 5: e13428.
26. Yamamoto N. Structural definition of a potent macrophage activating factor derived from vitamin D3-binding protein with adjuvant activity for antibody production. Mol Immunol. 1996; 33: 1157-64.
27. Ikeda T, Kasai M, Suzuki J, et al. Multimerization of the receptor activator of nuclear factor-kappaB ligand (RANKL) isoforms and regulation of osteoclastogenesis. J Biol Chem. 2003; 278: 47217-22.
28. Chun RF. New perspectives on the vitamin D binding protein. Cell Biochem Funct. 2012; 30: 445-56.
29. Zella LA, Shevde NK, Hollis BW, et al. Vitamin D-binding protein influences total circulating levels of 1, 25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology. 2008; 149: 3656-67.
30. Bikle DD, Siiteri PK, Ryzen E, et al. Serum protein binding of 1, 25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab. 1985; 61: 969-75.
31. Piquette CA, Robinson-Hill R, Webster RO. Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin. J Leukoc Biol. 1994; 55: 349-54.
32. Kew RR, Webster RO. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg. J Clin Invest. 1988; 82: 364-9.
33. Safadi FF, Thornton P, Magiera H, et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest. 1999; 103: 239-51.
34. Yamamoto N, Naraparaju VR. A defect in inducible beta-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse. Immunology. 1996; 88: 604-10.
35. Yamamoto N, Naraparaju VR. A defect in beta-galactosidase of B lymphocytes in the osteopetrotic (op/op) mouse. Immunol Lett. 1996; 50: 35-40.
36. Schneider GB, Benis KA, Flay NW, et al. Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. Bone. 1995; 16: 657-62.
37. Swamy N, Ghosh S, Schneider GB, et al. Baculovirus-expressed vitamin D-binding protein-macrophage activating factor (DBP-maf) activates osteoclasts and binding of 25-hydroxyvitamin D(3) does not influence this activity. J Cell Biochem. 2001; 81: 535-46.
38. Jorgensen CS, Christiansen M, Norgaard-Pedersen B, et al. Gc globulin (vitamin D-binding protein) levels: an inhibition ELISA assay for determination of the total concentration of Gc globulin in plasma and serum. Scand J Clin Lab Invest. 2004; 64: 157-66.
39. Lauridsen AL, Vestergaard P, Nexo E. Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem. 2001; 47: 753-6.
40. Abbas AK, Lichtman AH. Cellular and molecular immunology, 5th edn. Philadelphia: Elsevier Saunders, 2005.
41. Mangham DC, Scoones DJ, Drayson MT. Complement and the recruitment of mononuclear osteoclasts. J Clin Pathol. 1993; 46: 517-21.
42. Sato T, Abe E, Jin CH, et al. The biological roles of the third component of complement in osteoclast formation. Endocrinology. 1993; 133: 397-404.
43. Ignatius A, Schoengraf P, Kreja L, et al. Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1beta. J Cell Biochem. 2011; 112: 2594-605.
44. Tu Z, Bu H, Dennis JE, et al. Efficient osteoclast differentiation requires local complement activation. Blood. 2010; 116: 4456-63.
45. Kawasaki T, Takahashi S, Ikeda K. Hydroxyapatite high-performance liquid chromatography: column performance for proteins. Eur J Biochem. 1985; 152: 361-71.